1 March 2026 - The March 2026 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are a few major new listings of note this month:

• Etanercept (Enbrel) - restriction change
• Infliximab (Remicade) - restriction change 
• Iron isomaltoside (Monofer) - new formulation
• Rituximab (MabThera) - restriction change
• Secukinumab (Cosentyx) - restriction change

Read New Zealand Pharmaceutical Schedule update